SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
BLANKENSHIP EDWARD H

(Last) (First) (Middle)
4991 CORPORATE DRIVE

(Street)
HUNTSVILLE AL 35805

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AVOCENT CORP [ AVCT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior VP Finance & CFO
3. Date of Earliest Transaction (Month/Day/Year)
04/27/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/27/2007 A 9,677(5) A $0 29,188(4)(6) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (rights to buy) $15.46 07/25/2002(1) 07/25/2012 Common Stock 25,000 25,000 D
Options (rights to buy) $27.25 03/07/2003(2) 03/07/2013 Common Stock 10,000 10,000 D
Options (rights to buy) $40.98 02/05/2004(2) 02/05/2014 Common Stock 10,000 10,000 D
Options (rights to buy) $28.96 08/19/2004(2) 08/19/2014 Common Stock 5,000 5,000 D
Options (rights to buy) $26.14 06/30/2005(3) 06/30/2015 Common Stock 3,000 3,000 D
Explanation of Responses:
1. Grant date, options vest over four years, 25% on the first anniversary of the grant date and 6.25% quarterly over the remaining 12 quarters.
2. Grant date, 25% vests after 6 months, 7.5% vests every three months for the final 10 quarters. Vesting of unvested options accelerated and became 100% vested on December 25, 2005.
3. Grant date, 100% vested on December 31, 2005.
4. Includes time-based and performance-based (now deemed earned) restricted shares awarded on April 25, 2006: 967 shares vest on January 1, 2008; 5,734 shares vest equally over two years, one-half on January 1, 2008 and one-half on January 1, 2009.
5. These are time-based restricted shares granted on April 27, 2007. The shares vest equally over three years, one-third on January 1, 2008, one-third on January 1, 2009 and one-third January 1, 2010.
6. The balance includes a correction for a mathematical error made on a previously filed form 4. The activity for the underlying transaction was reported properly and in a timely manner.
Richard K. Hempstead Attorney-in-Fact for Edward H. Blankenship 05/01/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.